|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.9 NOK | -0.83% |
|
0.00% | +2.58% |
| Mar. 04 | Vistin Pharma ASA (OB:VISTN) acquired 15% stake in CF Pharma Ltd. for ?1.6 million. | CI |
| Feb. 16 | Vistin Pharma ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
The current CEO of Weifa ASA, Kjell-Erik Nordby, will be appointed CEO of Vistin Pharma. CEO Kjell-Erik Nordby will lead Weifa until Vistin Pharma is listed on Oslo Axess. From the same day, he will take over as CEO of Vistin Pharma.
Ole Enger will be the chairman in Vistin Pharma. Mr. Enger is one of the most experienced professionals in the Norwegian manufacturing industry, and his previous experience includes positions as the CEO of both Elkem and REC.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.58% | 96.97M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
VISTIN PHARMA ASA 
